Skip to Main Content

Author Details

Jakub Z??vada
Institute of Rheumatology, Charles University
2003
61
20
PMIDPaper TitleJournal TitlePublished Year
36463635Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].Semin Arthritis Rheum2023
37738257Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.Rheumatology (Oxford)2023
37601339Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.Lancet Reg Health Eur2023
37045835Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease.NPJ Parkinsons Dis2023
37208028New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis.RMD Open2023
34599798Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF.Rheumatology (Oxford)2022
35985172Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.Semin Arthritis Rheum2022
34940840European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.Rheumatology (Oxford)2022
35338383The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.Rheumatol Int2022
32238520Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases.J Rheumatol2021
34745117IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.Front Immunol2021
34352609Patients with REM sleep behavior disorder have higher serum levels of allantoin.Parkinsonism Relat Disord2021
34083206Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.Ann Rheum Dis2021
33407803Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry.Arthritis Res Ther2021
311677582018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.Ann Rheum Dis2020
31747555Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress.Anal Biochem2020
31736377Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.Expert Opin Biol Ther2020
32950963Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.RMD Open2020
32349791Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis.Arthritis Res Ther2020
31416921Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I).J Rheumatol2020
30620295Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry.Clin Exp Rheumatol2019
31363829Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.Rheumatol Int2019
31098882EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review.Eur J Health Econ2019
30719969S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals.Clin Exp Rheumatol2019
30392117Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.Rheumatol Int2019
29350378EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.Kardiol Pol2018
30012548The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies.JMIR Res Protoc2018
29656372Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.Clin Rheumatol2018
293017832017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.Ann Rheum Dis2018
27307502Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.Ann Rheum Dis2017
28086960The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study.Arthritis Res Ther2017
28968913Functional non-synonymous variants of ABCG2 and gout risk.Rheumatology (Oxford)2017
28832684Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.PLoS One2017
28849432EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.Rheumatol Int2017
28822981Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.Ann Rheum Dis2017
28032847Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.Clin Exp Rheumatol2017
274575142016 updated EULAR evidence-based recommendations for the management of gout.Ann Rheum Dis2017
25165033A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.Ann Rheum Dis2016
26574749Microarray analysis of circulating micro RNAs in the serum of patients with polymyositis and dermatomyositis reveals a distinct disease expression profile and is associated with disease activity.Clin Exp Rheumatol2016
26428519Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis.Rheumatology (Oxford)2016
27832086Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.PLoS One2016
27472992EQ-5D in Central and Eastern Europe: 2000-2015.Qual Life Res2016
25433042The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers.Rheumatology (Oxford)2015
26373925Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.Arthritis Res Ther2015
26608564Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.Arthritis Res Ther2015
26704903Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.Arthritis Res Ther2015
25489637High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.Biomarkers2015
23644671The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.Ann Rheum Dis2014
24058015Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries.Ann Rheum Dis2014
24213308Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.Lupus2014
  • 1 - 50 of 61

Recommended Authors

Dennisse Bonilla
Toronto Western Hospital and Schroeder Arthritis Institute, University Health Network
Career Start Year 2016
Number of shared co-authors 0
Peter C Grayson
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 2011
Number of shared co-authors 0
Stacey Morrison
Duke University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Rachel Knevel
Leiden University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Carolina Mu??oz-Grajales
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 2009
Number of shared co-authors 0
Peggy Sekula
Institute of Genetic Epidemiology, University of Freiburg
Career Start Year 2008
Number of shared co-authors 0
Rajaie Namas
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 2
Zahi Touma
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 2005
Number of shared co-authors 0
Zachary S Wallace
Massachusetts General Hospital, and Harvard Medical School.
Career Start Year 2005
Number of shared co-authors 0
Veena K Ranganath
University of California, David Geffen School of Medicine los angeles
Career Start Year 2005
Number of shared co-authors 0
Sindhu R Johnson
Toronto Western Hospital, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
John M Davis
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
Jasvinder A Singh
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
Lorenzo Beretta
Scleroderma Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 2001
Number of shared co-authors 0
Shinsuke Yasuda
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Xinping Tian
Peking Union Medical College Hospital (PUMCH)
Career Start Year 1998
Number of shared co-authors 0
Michael Rudnicki
Medical University Innsbruck
Career Start Year 1997
Number of shared co-authors 0
Hans-Joachim Anders
University Hospital of the Ludwig Maximilians University Munich
Career Start Year 1995
Number of shared co-authors 1
Hanno B Richards
Novartis Pharma AG
Career Start Year 1995
Number of shared co-authors 0
Thomas Hauser
Kepler University Hospital, Johannes Kepler University
Career Start Year 1994
Number of shared co-authors 0
Paul R Fortin
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Career Start Year 1991
Number of shared co-authors 0
S Louis Bridges
Hospital for Special Surgery and Weill Cornell Medical College
Career Start Year 1989
Number of shared co-authors 1
Peter A Merkel
University of Pennsylvania Perelman School of Medicine
Career Start Year 1988
Number of shared co-authors 1
Chaim Putterman
Albert Einstein College of Medicine
Career Start Year 1986
Number of shared co-authors 0
Bhaskar Dasgupta
Southend Hospital NHS Trust
Career Start Year 1983
Number of shared co-authors 1
John D Reveille
University of Texas
Career Start Year 1983
Number of shared co-authors 0
Brad H Rovin
the Ohio State University Wexner Medical Center
Career Start Year 1980
Number of shared co-authors 1
Arthur Bookman
University of Toronto
Career Start Year 1976
Number of shared co-authors 0
Dafna D Gladman
Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital
Career Start Year 1975
Number of shared co-authors 0
Murray B Urowitz
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 1966
Number of shared co-authors 0

Collaborators

William G Dixon
The University of Manchester
Co-authored papers 5
Irene E van der Horst-Bruinsma
Co-authored papers 3
Piet L C M van Riel
Co-authored papers 2
Rodrigo Cartin-Ceba
Mayo Clinic Arizona
Co-authored papers 1
G Clermont
University of Pittsburgh
Co-authored papers 1
Annette H M van der Helm-van Mil
Co-authored papers 1
Rinaldo Bellomo
Royal Melbourne Hospital
Co-authored papers 1
Ognjen Gajic
Mayo Clinic
Co-authored papers 1
Eric Hoste
Ghent University Hospital, and Research Foundation Flanders (FWO), Ghent University
Co-authored papers 1
Paolo Calzavacca
University of Milano-Bicocca
Co-authored papers 1
John A Kellum
Spectral Medical Inc.
Co-authored papers 1
Release 1.2